Medical Xpress October 22, 2024
Taylor & Francis

A new advanced artificial intelligence (AI) tool, developed by renal doctors internationally, represents a significant step forward in predicting and potentially improving outcomes for UK kidney transplant patients.

For patients with late-stage , a can be life-changing, offering the promise of improved survival and a better quality of life compared to other treatment options. But in the UK alone, around 5,000 people are on the waiting list for a kidney transplant, with an average wait time of two to three years for a deceased donor organ.

A team of experts from hospitals across the US and UK have created new software, which could ultimately pave the way for updated kidney allocation policies—potentially leading to better patient outcomes...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Patient / Consumer, Provider, Technology
Microsoft’s 10 new AI agents strengthen its enterprise automation lead
Learning the Language of Life with A.I.
How Payers are Using AI to Deny Claims and Dent Provider Revenue
4 Issues That Fall Between The Cracks Of Our AI Excitement
Generative AI Is Helping To Clear Up Brain Fog

Share This Article